Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention Or Treatment of Postmenopausal Osteoporosis
| Author | : United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products |
| Publisher | : |
| Total Pages | : 20 |
| Release | : 1994 |
| ISBN-10 | : OCLC:35209809 |
| ISBN-13 | : |
| Rating | : 4/5 ( Downloads) |
Book Synopsis Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention Or Treatment of Postmenopausal Osteoporosis by : United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products
Download or read book Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention Or Treatment of Postmenopausal Osteoporosis written by United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products and published by . This book was released on 1994 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt:
